Abstract
* There are many ways of analyzing the progress of an epidemic, but when it comes to short term forecasting, it is very hard to beat a simple time series regression model. These are good at allowing for the noise in day to day observations, extracting the trend and projecting it forward.
* Our regression models are designed to exploit this, using the daily statistics released by PHE and NHSE. These strongly suggest that the tide has turned and that taking one day with the next, the national figures for deaths from this virus will now fall back noticeably, easing the pressure on the NHS and its staff.
* There is still a huge range of uncertainty associated with any forecast. The model is currently predicting a total of 113,000 admissions to UK hospitals by the end of April and that 19,000 people will die from the virus in English hospitals by then. There is a 1 in 20 chance that the mortality figures could flatten out more quickly, with around 1,000 more deaths occurring by the end of April. However, there is the same risk that this figure continues to mount, rising to a total of 24,000 by the end of the month. On current trends, the number of deaths in the UK is likely to be 10% higher than the number in England.
* Longer term, the impact of the virus will depend critically upon the likely relaxation of the current government strategy of suppression.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Personal unfunded research.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
adam.golinski{at}york.ac.uk.
Data Availability
PSE and NHSE data in the public domain
